Press Release
Global Biological Drugs Market is Estimated to Reach $394 Billion by 2024, Says Variant Market Research
 Published Date:  Aug 2017  Publish By: Variant Market Research

Global Biological Drugs Market Report, published by Variant Market Research, forecast that the global market is expected to reach $394 Billion by 2024 from $180 Billion in 2016, growing at a CAGR of 10.3% from 2016 to 2024. By geography, Asia Pacific and Europe are expected to grow at a CAGR of 11.4% and 10.8%, respectively, during the forecast period.

"Biological Drugs Market (By Product Type: Therapeutic Protein, Monoclonal Antibody, and Vaccine; By Geography: North America, Europe, Asia-Pacific, and RoW) Global Scenario, Market Size, Outlook, Trend, and Forecast, 2015-2024"

To browse the complete report, visit at: https://www.variantmarketresearch.com/report-categories/pharmaceuticals/biological-drugs-market

The factors driving the growth of the global biological drugs market are increasing geriatric population, growing prevalence of lifestyle and chronic diseases, increasing R&D budgets, and growing government initiatives supporting the adoption of biological drugs. Though, high cost of biological drugs and possibility of adverse effects may limit the growth of the market. Additionally, advancements in technology and lower cost of these medications would provide several growth opportunities in coming years.

Product type and geography are the key segments considered in the global biological drugs market. By product type, the market is categorized into therapeutic protein (Enbrel, Lantus, Neulasta, Avones, Novolog, Rebif, Humalog, Aranesp, Epogen, Levemir, Victoza, Betaseron, Neupogen, Eylea And Others), monoclonal antibody (Humira, Remicade, Rituxan, Avastin, Herceptin, Lucentis, And Others) and vaccine (Prevnar 13, Gardasil, Fluzone, Varivax, Cervarix, and Others). Among which, therapeutic proteins held the largest market share in 2016, followed by monoclonal antibody.

By geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America and Europe accounted for majority of the market share with 49.5% and 27.0%, respectively in 2016. Moreover, in terms of growth, Asia-Pacific is expected to grow with the fastest CAGR of 11.4% during the forecast period 2016 to 2024, driven by, high adoption of generic drugs, increasing government budgets in R&D and low manufacturing costs.

Major companies operating in this market comprises, Baxter International Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Amgen Inc., Biogen Inc., GlaxoSmithKline Plc, Novartis AG, Eli Lilly and Co., Pfizer Inc., and Abbott Laboratories, among others.

Contact Us:

John Dave,
Head - Sales 
Variant Market Research
649 Mission St, 5th Floor, San Francisco, CA 94105, United States.
Tel: +91-953-444-8373
Email: john.dave@variantmarketresearch.com 
Email: help@variantmarketresearch.com


GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Chapter 1 Prefix
    1.1 Market Scope
    1.2 Report Description
    1.3 Research Methodology
          1.3.1 Primary Research
          1.3.2 Secondary Research
          1.3.3 In-house Data Modeling
Chapter 2 Executive Summary
Chapter 3 Market Outline
    3.1 Market Inclination, Trend, Outlook and Viewpoint
    3.2 Market Share Analysis: Company’s Competitive Scenario
    3.3 Market Dynamics
          3.3.1 Drivers
                   3.3.1.1 Impact Analysis
          3.3.2 Restraints
                   3.3.2.1 Impact Analysis
          3.3.3 Opportunities
Chapter 4 Biological Drugs Market by Product Type: Market Size and Forecast, 2015 – 2024
    4.1 Overview
    4.2 Therapeutic Protein
          4.2.1 Current Trend and Analysis
          4.2.2 Market Size and Forecast
          4.2.3 Enbrel
          4.2.4 Lantus
          4.2.4 Neulasta
          4.2.6 Avones
          4.2.7 Novolog
          4.2.8 Rebif
          4.2.9 Humalog
          4.2.10 Aranesp
          4.2.11 Epogen
          4.2.12 Levemir
          4.2.13 Victoza
          4.2.14 Betaseron
          4.2.15 Neupogen
          4.2.16 Eylea
          4.2.17 Other Therapeutic Proteins
    4.3 Monoclonal Antibody
          4.3.1 Current Trend and Analysis
          4.3.2 Market Size and Forecast
          4.3.3 Humira
          4.3.4 Remicade
          4.3.5 Rituxan
          4.3.6 Avastin
          4.3.7 Herceptin
          4.3.8 Lucentis
          4.3.9 Other Monoclonal Antibodies
    4.4 Vaccine
          4.4.1 Current Trend and Analysis
          4.4.2 Market Size and Forecast
          4.4.3 Prevnar
          4.4.4 Gardasil
          4.4.5 Fluzone
          4.4.6 Varivax
          4.4.7 Cervarix
          4.4.8 Other Vaccines
Chapter 5 Biological Drugs Market by Geography: Market Size and Forecast, 2015 – 2024
    5.1 Overview
    5.2 North America
          5.2.1 Current Trend and Analysis
          5.2.2 Market Size and Forecast
          5.2.3 US
                   5.2.3.1 Market Size and Forecast
          5.2.4 Canada
                   5.2.4.1 Market Size and Forecast
          5.2.5 Mexico
                   5.2.5.1 Market Size and Forecast
    5.3 Europe
          5.3.1 Current Trend and Analysis
          5.3.2 Market Size and Forecast
          5.3.3 UK
                   5.3.3.1 Market Size and Forecast
          5.3.4 Germany
                   5.3.4.1 Market Size and Forecast
          5.3.5 France
                   5.3.5.1 Market Size and Forecast
          5.3.6 Italy
                   5.3.6.1 Market Size and Forecast
          5.3.7 Others
                   5.3.7.1 Market Size and Forecast
    5.4 Asia-Pacific
          5.4.1 Current Trend and Analysis
          5.4.2 Market Size and Forecast
          5.4.3 India
                   5.4.3.1 Market Size and Forecast
          5.4.4 South Korea
                   5.4.4.1 Market Size and Forecast
          5.4.5 Japan
                   5.4.5.1 Market Size and Forecast
          5.4.6 China
                   5.4.6.1 Market Size and Forecast
          5.4.7 Others
                   5.4.7.1 Market Size and Forecast
    5.5 RoW
          5.5.1 Current Trend and Analysis
          5.5.2 Market Size and Forecast
          5.5.3 Middle East
                   5.5.3.1 Market Size and Forecast
          5.5.4 South America
                   5.5.4.1 Market Size and Forecast
          5.5.5 Africa
                   5.5.5.1 Market Size and Forecast
Chapter 6 Company Profiles
    6.1 Baxter International Inc.
    6.2 Bristol-Myers Squibb Company
    6.3 Merck & Co., Inc.
    6.4 Amgen Inc.
    6.5 Biogen Inc.
    6.6 GlaxoSmithKline Plc
    6.7 Novartis AG
    6.8 Eli Lilly and Co.
    6.9 Pfizer Inc.
    6.10 Abbott Laboratories

GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Please fill the form below and our research expert will get in touch with you.


Refresh Captcha

Please fill the form below and our research expert will get in touch with you.


Refresh Captcha